Methylation at CpG sites related to growth differentiation factor-15 was not prospectively associated with cardiovascular death in discordant monozygotic twins
Abstract Myocardial infarction patients had decreased methylation at four growth differentiating factor-15 (GDF-15) related CpG sites (cg13033858, cg16936953, cg17150809, and cg18608055). These sites had not been studied for their association with cardiovascular disease (CVD) deaths. Thus, we aimed...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2022-03-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-022-08369-9 |
| _version_ | 1818321013178368000 |
|---|---|
| author | Spencer Shawn Moore Pallavi Mukherji Ming Leung Catherine E. Vrentas Melsa M. Mwanja Jun Dai |
| author_facet | Spencer Shawn Moore Pallavi Mukherji Ming Leung Catherine E. Vrentas Melsa M. Mwanja Jun Dai |
| author_sort | Spencer Shawn Moore |
| collection | DOAJ |
| description | Abstract Myocardial infarction patients had decreased methylation at four growth differentiating factor-15 (GDF-15) related CpG sites (cg13033858, cg16936953, cg17150809, and cg18608055). These sites had not been studied for their association with cardiovascular disease (CVD) deaths. Thus, we aimed to assess the associations independent of genes, shared environment, and traditional CVD risk factors. Nineteen white, male, monozygotic twin pairs discordant for CVD deaths were included from the National Heart, Lung and Blood Institute Twin Study (NHLBI) initiated in 1969. Data on vital status was collected through December 31, 2014. Methylation of buffy coat DNA at exam 3 (1986–87) was measured using the Illumina HumanMethylation450 BeadChip. Principal component analysis was used to generate a score representing blood leukocyte composition and baseline CVD risk factors and predominated with natural killer cells, CD4+ T cells, and Framingham risk score. Conditional logistic regression demonstrated that methylation at the four CpG sites was not associated with CVD deaths before (all p > 0.05, bootstrapped p > 0.05) and after adjustment for the score (all p > 0.05). Joint influences of cg16936953 and the score were statistically significant (p < 0.05). In conclusion, joint influences of methylation at the site cg16936953 and the score are prospectively associated with CVD deaths independent of germline and common environment. ClinicalTrials.gov Identifier for NHLBI Twin Study: NCT00005124. |
| first_indexed | 2024-12-13T10:34:09Z |
| format | Article |
| id | doaj.art-acfbea42b8c84f6783712c90595fc176 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-12-13T10:34:09Z |
| publishDate | 2022-03-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-acfbea42b8c84f6783712c90595fc1762022-12-21T23:50:46ZengNature PortfolioScientific Reports2045-23222022-03-011211910.1038/s41598-022-08369-9Methylation at CpG sites related to growth differentiation factor-15 was not prospectively associated with cardiovascular death in discordant monozygotic twinsSpencer Shawn Moore0Pallavi Mukherji1Ming Leung2Catherine E. Vrentas3Melsa M. Mwanja4Jun Dai5Doctoral Program of Osteopathic Medicine, College of Osteopathic Medicine, Des Moines UniversityEmergency Medicine Residency Program, Loyola University Medical CenterInstitute for Personalized Medicine, Penn State College of MedicineMaster Program of Public Health, Des Moines UniversityOregon State Department of Human ServicesDepartment of Public Health, College of Health Sciences, Des Moines UniversityAbstract Myocardial infarction patients had decreased methylation at four growth differentiating factor-15 (GDF-15) related CpG sites (cg13033858, cg16936953, cg17150809, and cg18608055). These sites had not been studied for their association with cardiovascular disease (CVD) deaths. Thus, we aimed to assess the associations independent of genes, shared environment, and traditional CVD risk factors. Nineteen white, male, monozygotic twin pairs discordant for CVD deaths were included from the National Heart, Lung and Blood Institute Twin Study (NHLBI) initiated in 1969. Data on vital status was collected through December 31, 2014. Methylation of buffy coat DNA at exam 3 (1986–87) was measured using the Illumina HumanMethylation450 BeadChip. Principal component analysis was used to generate a score representing blood leukocyte composition and baseline CVD risk factors and predominated with natural killer cells, CD4+ T cells, and Framingham risk score. Conditional logistic regression demonstrated that methylation at the four CpG sites was not associated with CVD deaths before (all p > 0.05, bootstrapped p > 0.05) and after adjustment for the score (all p > 0.05). Joint influences of cg16936953 and the score were statistically significant (p < 0.05). In conclusion, joint influences of methylation at the site cg16936953 and the score are prospectively associated with CVD deaths independent of germline and common environment. ClinicalTrials.gov Identifier for NHLBI Twin Study: NCT00005124.https://doi.org/10.1038/s41598-022-08369-9 |
| spellingShingle | Spencer Shawn Moore Pallavi Mukherji Ming Leung Catherine E. Vrentas Melsa M. Mwanja Jun Dai Methylation at CpG sites related to growth differentiation factor-15 was not prospectively associated with cardiovascular death in discordant monozygotic twins Scientific Reports |
| title | Methylation at CpG sites related to growth differentiation factor-15 was not prospectively associated with cardiovascular death in discordant monozygotic twins |
| title_full | Methylation at CpG sites related to growth differentiation factor-15 was not prospectively associated with cardiovascular death in discordant monozygotic twins |
| title_fullStr | Methylation at CpG sites related to growth differentiation factor-15 was not prospectively associated with cardiovascular death in discordant monozygotic twins |
| title_full_unstemmed | Methylation at CpG sites related to growth differentiation factor-15 was not prospectively associated with cardiovascular death in discordant monozygotic twins |
| title_short | Methylation at CpG sites related to growth differentiation factor-15 was not prospectively associated with cardiovascular death in discordant monozygotic twins |
| title_sort | methylation at cpg sites related to growth differentiation factor 15 was not prospectively associated with cardiovascular death in discordant monozygotic twins |
| url | https://doi.org/10.1038/s41598-022-08369-9 |
| work_keys_str_mv | AT spencershawnmoore methylationatcpgsitesrelatedtogrowthdifferentiationfactor15wasnotprospectivelyassociatedwithcardiovasculardeathindiscordantmonozygotictwins AT pallavimukherji methylationatcpgsitesrelatedtogrowthdifferentiationfactor15wasnotprospectivelyassociatedwithcardiovasculardeathindiscordantmonozygotictwins AT mingleung methylationatcpgsitesrelatedtogrowthdifferentiationfactor15wasnotprospectivelyassociatedwithcardiovasculardeathindiscordantmonozygotictwins AT catherineevrentas methylationatcpgsitesrelatedtogrowthdifferentiationfactor15wasnotprospectivelyassociatedwithcardiovasculardeathindiscordantmonozygotictwins AT melsammwanja methylationatcpgsitesrelatedtogrowthdifferentiationfactor15wasnotprospectivelyassociatedwithcardiovasculardeathindiscordantmonozygotictwins AT jundai methylationatcpgsitesrelatedtogrowthdifferentiationfactor15wasnotprospectivelyassociatedwithcardiovasculardeathindiscordantmonozygotictwins |